Market Research Logo

Molecular Diagnostics: Technologies and Global Markets

Molecular Diagnostics: Technologies and Global Markets

The global molecular diagnostics market was valued at almost $21.7 billion in 2014. The total market is projected to grow at a compound annual growth rate (CAGR) of 12.5% from 2015 through 2020 to reach nearly $25.2 billion by 2015 and $45.2 billion by 2020.

This report provides:

An overview of the global market for molecular diagnostics.

Analyses of global market trends, with data from 2012, 2013 and 2014 estimates for 2015, and projections of CAGRs through 2020.

Discussion of related issues, such as government regulation, reimbursement through insurance, patient confidentiality, and other legal ramifications.

Identification of scientific challenges and advances, including the latest trends in the market.

A relevant patent analysis.

Comprehensive company profiles of major players in the field of molecular diagnostics.


SCOPE OF REPORT

This study examines the global market for assays used to detect specific nucleic acid sequences in medical and life sciences applications. While the goal of all DNA-based diagnostic assays is similar, several different technologies can be employed. BCC Research analyzes each technology in detail, determines major players and current market status and presents forecasts of growth over the next five years. Scientific challenges and advances including the latest trends are emphasized. We examine government regulations, major collaborations, recent patents and factors affecting the industry globally. In addition, we examine new directions for DNA diagnostic technologies and emerging applications in clinical diagnostics.

CHAPTER 1 INTRODUCTION
STUDY GOALS AND OBJECTIVES
REASONS FOR DOING THE STUDY
SCOPE OF REPORT
INTENDED AUDIENCE
METHODOLOGY AND INFORMATION SOURCES
ANALYST'S CREDENTIALS
RELATED BCC RESEARCH REPORTS
BCC RESEARCH WEBSITE
DISCLAIMER
CHAPTER 2 SUMMARY
FORECASTS
SUMMARY TABLE GLOBAL MARKET FOR MOLECULAR DIAGNOSTICS BY TECHNOLOGY, THROUGH 2020 ($ MILLIONS)
SUMMARY FIGURE GLOBAL MARKET FOR MOLECULAR DIAGNOSTICS BY TECHNOLOGY, 2012-2020 ($ MILLIONS)
VENDORS
CHAPTER 3 OVERVIEW
OVERVIEW
INTRODUCTION TO GENOMIC DIAGNOSTICS
EXPRESSION PROFILING AND DISEASE
EXPRESSION PROFILING AND INFECTIOUS DISEASE
DNA SEQUENCING FOR GENOTYPING AND DIAGNOSIS
CLINICAL PHARMACOLOGY
MUTATION DETECTION AND GENOTYPING FOR SPECIFIC GENES
IDENTIFICATION OF NEW DISEASE GENES
CHAPTER 4 REGULATIONS AND FINANCE
OVERVIEW
INSURANCE
FOOD AND DRUG ADMINISTRATION GUIDELINES
INTERNAL STANDARDS FOR DNA DIAGNOSTICS
TABLE 1 MINIMUM INFORMATION ABOUT A MICROARRAY EXPERIMENT - MIAME 2.0
TABLE 2 MICROARRAY QUALITY CONTROL (MAQC) PROJECT
CLINICAL LABORATORY IMPROVEMENT AMENDMENTS (CLIA)
TABLE 3 U.S. LABORATORIES CLIA-CERTIFIED FOR MOLECULAR
DIAGNOSTICS AND NUMBER OF DISEASE TESTS, 2012
FIGURE 1 GROWTH IN CLINICAL LABORATORY SITES AND DISEASE TESTING, 1993-2015
TABLE 4 GENETIC TESTING PROCEDURES PERFORMED IN U.S. BY TYPE, 2015
PERSONALIZED MEDICINES AND COMPANION DIAGNOSTICS
FDA GUIDELINES FOR IN VITRO COMPANION DIAGNOSTICS
Definition and Use of an IVD Companion Diagnostic Device
Review and Approval of IVD Companion Diagnostic Devices and Therapeutic Products
Novel Therapeutic Products
Approval of a Therapeutic Product without an Approved IVD
Companion Diagnostic Device
General Policies
FDA-APPROVED COMPANION DIAGNOSTICS
TABLE 5 FDA-APPROVED IN VITRO COMPANION DIAGNOSTIC DEVICES AS OF DEC. 23, 2014
TABLE 6 FDA-APPROVED IN VITRO COMPANION DIAGNOSTIC DEVICES, AS OF DECEMBER 2012
PHARMACOGENOMICS RESEARCH NETWORK
TABLE 7 CURRENT PGRN-RIKEN CGM COLLABORATIVE STUDIES
CHAPTER 5 COMMERCIAL MARKET TRENDS
MARKET CONDITIONS
HEALTHCARE, HOSPITALS, DOCTORS, GREATER REGULATION AND NEED
FOR INSURANCE REIMBURSEMENT
NEW REQUIREMENTS FOR SUCCESS
SALES AND MARKETING
MEDICAL AFFAIRS
REGULATORY COMPLIANCE
REIMBURSEMENT
ALLIANCES AND MERGERS
TABLE 8 DIAGNOSTICS MANUFACTURER MERGERS AND ACQUISITIONS, 2004-2014
CHAPTER 6 MARKET FOR MOLECULAR DIAGNOSTICS BY TECHNOLOGY
OVERVIEW
DESCRIPTION
REVENUES AND FORECASTS
TABLE 9 GLOBAL MARKET FOR MOLECULAR DIAGNOSTICS BY TECHNOLOGY, THROUGH 2020 ($ MILLIONS)
TABLE 10 GLOBAL MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY TECHNOLOGY, 2015 (%)
FIGURE 2 GLOBAL MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY TECHNOLOGY, 2015 (%)
MANUFACTURERS
TABLE 11 GLOBAL MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY MANUFACTURER, 2015 (%)
FIGURE 3 GLOBAL MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY MANUFACTURER, 2015 (%)
MICROARRAY
DESCRIPTION
Planar
Bead
REVENUES AND FORECASTS
TABLE 12 GLOBAL MICROARRAY MARKET FOR MOLECULAR DIAGNOSTICS BY APPLICATION, THROUGH 2020 ($ MILLIONS)
TABLE 13 GLOBAL MICROARRAY MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)
FIGURE 4 GLOBAL MICROARRAY MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)
MANUFACTURERS AND PRODUCTS
Planar
TABLE 14 MAJOR SUPPLIERS OF PLANAR DNA MICROARRAYS
Bead
TABLE 15 MAJOR SUPPLIERS OF BEAD MICROARRAYS
PCR
DESCRIPTION
REVENUES AND FORECASTS
TABLE 16 GLOBAL PCR MARKET FOR MOLECULAR DIAGNOSTICS BY APPLICATION, THROUGH 2020 ($ MILLIONS)
TABLE 17 GLOBAL PCR MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)
FIGURE 5 GLOBAL PCR MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)
MANUFACTURERS AND PRODUCTS
TABLE 18 GLOBAL PCR MARKET SHARE BY MANUFACTURER, 2015 (%)
IN SITU HYBRIDIZATION (ISH)
DESCRIPTION
Labeling Techniques
Applications of In Situ Hybridization
FIBER FISH
HER2 FISH TESTING
REVENUES AND FORECASTS
TABLE 19 GLOBAL ISH MARKET FOR MOLECULAR DIAGNOSTICS BY APPLICATION, THROUGH 2020 ($ MILLIONS)
TABLE 20 GLOBAL ISH MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)
FIGURE 6 GLOBAL ISH MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)
LAB-ON-A-CHIP/BIOCHIPS
DESCRIPTION
Microfluidic Devices
PRODUCT DEVELOPMENT
REVENUES AND FORECASTS
TABLE 21 GLOBAL LAB-ON-A-CHIP/BIOCHIP MARKET FOR MOLECULAR DIAGNOSTICS BY APPLICATION, THROUGH 2020 ($ MILLIONS)
TABLE 22 GLOBAL LAB-ON-A-CHIP/BIOCHIP MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)
FIGURE 7 GLOBAL LAB-ON-A-CHIP/BIOCHIP MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)
EMERGING AND OTHER DIAGNOSTIC TECHNOLOGIES
DESCRIPTION
The Trend toward Single-Cell Measurements
Genetic Typing of Single Cells
Single-Cell Sequencing
Copy Number Variations in Single Cells
Combined Immunotyping and Single-Cell Expression Analysis
Diagnosing the Epigenome
REVENUES AND FORECASTS
TABLE 23 GLOBAL EMERGING/OTHER MOLECULAR DIAGNOSTICS MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)
TABLE 24 GLOBAL EMERGING/OTHER MOLECULAR DIAGNOSTICS MARKET SHARE BY APPLICATION, 2015 (%)
CHAPTER 7 MARKETS FOR MOLECULAR DIAGNOSTICS BY APPLICATION
AND PRODUCTS
OVERVIEW
DESCRIPTION
REVENUES AND FORECASTS
TABLE 25 GLOBAL MARKET FOR MOLECULAR DIAGNOSTICS BY APPLICATION, THROUGH 2020 ($ MILLIONS)
TABLE 26 GLOBAL MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)
FIGURE 8 GLOBAL MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)
PRE-/POSTNATAL GENETIC SCREENING
DESCRIPTION
Carrier Screening
Prenatal Diagnostic Testing
Amniocentesis
Chorionic Villus Sampling
Genetic Counseling
Preimplantation Diagnosis
Newborn Screening
REVENUES AND FORECASTS
TABLE 27 GLOBAL PRE/POSTNATAL SCREENING MARKET FOR MOLECULAR DIAGNOSTICS BY APPLICATION, THROUGH 2020 ($ MILLIONS)
TABLE 28 GLOBAL PRE/POSTNATAL SCREENING MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)
FIGURE 9 GLOBAL PRE/POSTNATAL SCREENING MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)
INFECTIOUS DISEASE DIAGNOSTICS
DESCRIPTION
REVENUES AND FORECASTS
TABLE 29 GLOBAL INFECTIOUS DISEASES MARKET FOR MOLECULAR DIAGNOSTICS BY APPLICATION, THROUGH 2020 ($ MILLIONS)
TABLE 30 GLOBAL INFECTIOUS DISEASE SCREENING MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)
FIGURE 10 GLOBAL INFECTIOUS DISEASE SCREENIN MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)
ONCOLOGY DIAGNOSTICS
DESCRIPTION
Leukemias
Chronic Myeloid Leukemia
Genetic Marker of Chronic Myeloid Leukemia
REVENUES AND FORECASTS
TABLE 31 GLOBAL ONCOLOGY MARKET FOR MOLECULAR DIAGNOSTICS BY APPLICATION, THROUGH 2020 ($ MILLIONS)
TABLE 32 GLOBAL ONCOLOGY MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)
FIGURE 11 GLOBAL ONCOLOGY MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)
IDENTITY DIAGNOSTICS, FORENSICS AND PATERNITY
DESCRIPTION
Paternity Testing
Technology
Accreditation
Legal Issues
Veterinary Identity Testing
REVENUES AND FORECASTS
TABLE 33 GLOBAL IDENTITY TESTING MARKET FOR MOLECULAR DIAGNOSTICS BY APPLICATION, THROUGH 2020 ($ MILLIONS)
TABLE 34 GLOBAL IDENTITY TESTING MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)
FIGURE 12 GLOBAL IDENTITY TESTING MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)
PHARMACOGENOMICS/OTHER APPLICATIONS
DESCRIPTION
REVENUES AND FORECASTS
TABLE 35 GLOBAL PHARMACOGENOMICS AND OTHER MARKET FOR MOLECULAR DIAGNOSTICS BY APPLICATION, THROUGH 2020 ($ MILLIONS)
TABLE 36 GLOBAL PHARMACOGENOMICS AND OTHER MARKET SHARE FOR MOLECULAR DIAGNOSTICS BY APPLICATION, 2015 (%)
CHAPTER 8 PATENT ANALYSIS
PCR
TABLE 37 SELECTED PCR PATENTS GRANTED FROM JANUARY 2013 TO
JANUARY 2015
REAL TIME PCR DETECTION OF RESPIRATORY SYNCYTIAL VIRUS
NUCLEIC ACID AMPLIFICATION PRIMERS FOR PCR-BASED CLONALITY STUDIES
QUANTITATIVE MULTIPLEX METHYLATION SPECIFIC PCR METHOD-
CMETHDNA, REAGENTS, AND ITS USE
REAL-TIME PCR DETECTION OF STREPTOCOCCUS PYOGENES
REAL-TIME PCR FOR THE DETECTION OF PATHOGENS
QUANTITATIVE MULTIPLEX METHYLATION-SPECIFIC PCR
REAL-TIME PCR DETECTION OF MYCOBACTERIUM TUBERCULOSIS COMPLEX
REAL TIME PCR DETECTION OF M. TUBERCULOSIS RESISTANT/SUSCEPTIBLE TO RIFAMPICIN AND/OR ISONIAZID
ABSOLUTE PCR QUANTIFICATION
COMPOSITIONS AND METHOD FOR MEASURING AND CALIBRATING
AMPLIFICATION BIAS IN MULTIPLEXED PCR REACTIONS
REAL-TIME PCR DETECTION OF SEASONAL INFLUENZA H1, H3 AND B
SUBTYPES
MULTIMODAL PCR TARGET DETECTION
COMPOSITION TO OVERCOME INHIBITORS IN PCR AND GROWTH CULTURES
MAGNETIC IMMUNO DIGITAL PCR ASSAY
CUTOFF POINT DELTA CT. METHOD FOR HER2 PCR TESTING IN BREAST
CANCER
METHODS AND COMPOSITIONS FOR PCR USING BLOCKED AND UNIVERSAL
PRIMERS
PCR ASSAYS AND REAGENTS FOR MOLECULAR DETECTION OF INFECTIOUS
AGENTS
RANDOM HOMOZYGOUS GENE PERTURBATION (RHGP) WITH THERMAL
ASSYMETRIC INTERLACED (TAIL)-PCR
MICRO RNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF OVARIAN CANCER USING A REAL-TIME
PCR PLATFORM
PCR METHODS FOR CHARACTERIZING THE 5' UNTRANSLATED REGION OF THE FMR1 AND FMR2 GENES
MULTIPLEX PCR-BASED TESTING OF CUTANEOUS SQUAMOUS CELL
CARCINOMA AND PSEUDOEPITHELIOMATOUS HYPERPLASIA AND METHODS FOR DISTINGUISHING THE SAME
IDENTIFICATION OF ANTIGEN-SPECIFIC ADAPTIVE IMMUNE RESPONSES USING ARM-PCR AND HIGH-THROUGHPUT SEQUENCING
QUANTITATIVE MULTIPLEX METHYLATION-SPECIFIC PCR
PCR DIAGNOSTICS OF DERMATOPHYTES AND OTHER PATHOGENIC FUNGI
HIGHLY MULTIPLEX PCR METHODS AND COMPOSITIONS
SINGLE TUBE QUANTITATIVE POLYMERASE CHAIN REACTION (PCR)
HIGHLY MULTIPLEX PCR METHODS AND COMPOSITIONS
IDENTIFICATION OF LINKAGE USING MULTIPLEX DIGITAL PCR
METHODS AND COMPOSITIONS TO ENABLE MULTIPLEX COLD-PCR
METHODS OF DIAGNOSING DISEASE USING OVERLAP EXTENSION PCR
HOT-START DIGITAL PCR
METHOD FOR DETECTION, DIFFERENTIATION AND QUANTIFICATION OF T
CELL POPULATIONS BY WAY OF REVERSE TRANSCRIPTION QUANTITATIVE
REAL TIME PCR (RT-QPCR) TECHNOLOGY
NDM-1 POLYMERASE CHAIN REACTION (PCR) ASSAY
DETECTION OF MICRO METASTASIS OF MELANOMA AND BREAST CANCER IN PARAFFIN-EMBEDDED TUMOR DRAINING LYMPH NODES BY MULTIMARKER
QUANTITATIVE RT-PCR
LATE-PCR
HEMOMOSAIC: HIGH-THROUGHPUT TECHNIQUE FOR RARE CELL DETECTION
IN LIQUID SAMPLES BY MASSIVELY MULTIPLEXED PCR IN A PHOTOLITHOGRAPHIC MATRIX
SERIAL QUANTITATIVE PCR ASSAY FOR DETECTION, SPECIES-DISCRIMINATION
AND QUANTIFICATION OF LEISHMANIA SPP. IN HUMAN SAMPLES
GENE DETECTING METHODS WITHOUT USING PCR
HIGHLY MULTIPLEX PCR METHODS AND COMPOSITIONS
PROCESS FOR DETECTION OF MULTIDRUG RESISTANT TUBERCULOSIS USING
REAL-TIME PCR AND HIGH RESOLUTION MELT ANALYSIS
ISOFORMS OF THE HUMAN SST5 RECEPTOR ORIGINATED BY ALTERNATIVE
SPLICING AND OLIGONUCLEOTIDE PAIRS TO DETECT THEM BY PCR
REAL TIME PCR ASSAY FOR DETECTION OF BACTERIAL RESPIRATORY
PATHOGENS
METHODS AND COMPOSITIONS RELATED TO CONTINUOUS FLOW THERMAL
GRADIENT PCR
METHOD FOR DETECTING MORE THAN ONE TARGET IN A PCR-BASED
APPROACH APPLYING AN UN-SPECIFIC DYE WHICH IS NOT
INTERFERING WITH THE EMISSION OF FLUOROPHORE-LABELED
PROBES
MICROARRAY
TABLE 38 SELECTED MICROARRAY PATENTS GRANTED, JANUARY 2013 TO MAY 2015
METHODS AND SYSTEMS FOR MANUFACTURE OF MICROARRAY ASSAY
SYSTEMS, CONDUCTING MICROFLUIDIC ASSAYS, AND MONITORING AND
SCANNING TO OBTAIN MICROFLUIDIC ASSAY RESULTS
SYMMETRICALLY BRANCHED POLYMER CONJUGATES AND MICROARRAY
ASSAYS
TWO-DIMENSIONAL PHOTONIC CRYSTAL MICROARRAY MEASUREMENT
METHOD AND APPARATUS FOR HIGHLY-SENSITIVE LABEL-FREE
MULTIPLE ANALYTE SENSING, BIOSENSING, AND DIAGNOSTIC ASSAY
SOURCE CONTROLLED DECODABLE MICROARRAY SYSTEM AND METHODS FOR USE
MICROARRAY BASED SAMPLE DETECTION SYSTEM
MICROARRAY FABRICATION SYSTEM AND METHOD
MICROARRAY FOR DETECTING VIABLE ORGANISMS
SERUM-BASED MIRNA MICROARRAY AND ITS USE IN DIAGNOSIS AND TREATMENT OF BARRETT'S ESOPHAGUS (BE) AND ESOPHAGEAL
ADENOCARCINOMA (EAC)
LUMINOPHORE-LABELED MOLECULES COUPLED WITH PARTICLES FOR MICROARRAY-BASED ASSAYS
Y-SHAPED PROBE AND VARIANT THEREOF, AND DNA MICROARRAY, KIT AND GENETIC ANALYSIS METHOD USING THE SAME
MICROARRAY-BASED ASSAY INTEGRATED WITH PARTICLES FOR ANALYZING
MOLECULAR INTERACTIONS
MICROARRAY FABRICATION SYSTEM AND METHOD
ALLERGEN MICROARRAY
PHOTONIC CRYSTAL MICROARRAY LAYOUTS FOR ENHANCED SENSITIVITY
AND SPECIFICITY OF LABEL-FREE MULTIPLE ANALYTE SENSING, BIOSENSING AND DIAGNOSTIC ASSAY
ISH
TABLE 39 SELECTED ISH PATENTS GRANTED, JANUARY 2013 TO MAY 2015
CELL PREPARATIONS AND CELL SUPPORTS AND THEIR USE IN THERANOSIS
ULTRA SENSITIVE METHOD FOR IN SITU DETECTION OF NUCLEIC ACIDS
BACH2 REPRESSION IN CELLS IN SITU HYBRIDIZATION METHOD AND BUFFER
BIOCHIP
TABLE 40 SELECTED BIOCHIP PATENTS GRANTED, JANUARY 2013 TO MAY 2015
BIOCHIP AND TARGET DNA QUANTITATIVE METHOD
UNITARY BIOCHIP PROVIDING SAMPLE-IN TO RESULTS-OUT PROCESSING AND METHODS OF MANUFACTURE
BIOCHIP AND FABRICATION THEREOF
UNITARY BIOCHIP PROVIDING SAMPLE-IN TO RESULTS-OUT PROCESSING AND METHODS OF MANUFACTURE
BIOCHIP ASSEMBLY AND ASSAY METHOD THEREOF
BIOCHIP
CHAPTER 9 COMPANY PROFILES
ABBOTT MOLECULAR
PRODUCT CATEGORIES
PARTNERSHIPS
ADVANDX INC.
AFFYMETRIX INC.
PRODUCTS
Agrigenomics Genotyping Solutions
Chromogenic RNA in situ Hybridization
Fluorescence RNA in situ Hybridization
AGILENT TECHNOLOGIES INC.
PRODUCTS
PCR/qPCR
AUTOGENOMICS INC.
PRODUCTS
BECKMAN COULTER INC. (OWNED BY DANAHER)
PRODUCTS
Pipeline
BECTON DICKINSON AND COMPANY
BIOMERIEUX SA
PRODUCTS
Argene Molecular Biology Range
BIO-RAD LABORATORIES
LIFE SCIENCE RESEARCH
CLINICAL DIAGNOSTICS
PRODUCTS
Amplification/PCR
Digital PCR
PrimePCR Assays and Panels
Real-Time PCR Detection Systems
Thermal Cyclers
PX1 PCR Plate Sealer
PCR Reagents
PCR Plastic Consumables
Amplification Software
Nucleic Acid Sample Preparation and Purification
CALIPER LIFE SCIENCES INC.
PRODUCTS
Microfluidics, Laboratory Automation and Liquid Handling
THE CARLYLE GROUP
CEPHEID
PRODUCTS
CURAGEN CORP. (ACQUIRED BY CELLDEX)
DECODE GENETICS
PRODUCTS AND SERVICES
DNA DIAGNOSTICS CENTER
SERVICES
ELITECH GROUP
EMD MILLIPORE
PRODUCTS
EUROGENTEC (OWNED BY KANEKA CORP.)
PRODUCTS
SERVICES
EXACT SCIENCES CORP.
GE HEALTHCARE
HOLOGIC INC.
PRODUCTS
HTG MOLECULAR DIAGNOSTICS
SERVICES
PRODUCTS
ILLUMINA
PRODUCTS
LABORATORY CORP. OF AMERICA (LABCORP)
LIFE TECHNOLOGIES
PRODUCTS
LUMINEX CORP
PRODUCTS
xMAP technology
xTAG Technology
MultiCode Technology
MICRONICS INC.
PRODUCTS
MYRIAD GENETICS
PRODUCTS
PRODUCTS IN DEVELOPMENT
NOVARTIS MOLECULAR DIAGNOSTICS
PRODUCTS
Development Strategy
Novartis Diagnostics Division Products
OXFORD GENE TECHNOLOGY IP LTD.
PRODUCTS
PATHOGENETIX
PROMEGA
QIAGEN N.V.
PRODUCTS
COMPANION DIAGNOSTICS
QUEST DIAGNOSTICS
PRODUCTS
IN DEVELOPMENT
ROCHE
TABLE 41 ROCHE-COMPANION DIAGNOSTICS PIPELINE JOINT ONCOLOGY
PHARMA AND DIAGNOSTICS
SAVYON DIAGNOSTICS
PRODUCTS
SEQUENOM INC.
PRODUCTS
APPLICATIONS
SIEMENS
SORENSON GENOMICS INC.
THERMO FISHER SCIENTIFIC INC.
TRANSGENOMIC INC.
PRODUCTS AND PIPELINES
Genetic Testing Services
In Development

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report